C. Nutt

发表

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

T. Golub, P. Tamayo, C. Ladd, 2003, Cancer research.

Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas

Catherine L Nutt, Masahiro Mizoguchi, David N Louis, 2004, Brain pathology.

Molecular Pathology of Nervous System Tumors

D. Louis, A. Stemmer-Rachamimov, C. Nutt, 2005 .

A multigene predictor of outcome in glioblastoma.

K. Aldape, M. Gilbert, M. Mehta, 2010, Neuro-oncology.

Astrocytomas to Chemotherapy Differential Response of Oligodendrogliomas and Chemosensitivity in Glial Cell Lineages Correlate with Differential Expression of Drug Resistance Genes and Updated

M. Noble, C. Nutt, J. Cairncross, 2000 .

O6-Methylguanine-DNA Methyltransferase in Tumors and Cells of the Oligodendrocyte Lineage

J. Cairncross, J. Costello, C. Nutt, 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

DeregulationofaSTAT3-Interleukin8SignalingPathway PromotesHumanGlioblastomaCellProliferationand Invasiveness

C. Nutt, 2008 .

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

D. Louis, C. Nutt, S. Camelo-Piragua, 2009, Acta Neuropathologica.

Brain enriched hyaluronan binding (BEHAB)/brevican increases aggressiveness of CNS-1 gliomas in Lewis rats.

S. Hockfield, C. Nutt, C L Nutt, 2001, Cancer research.

Faculty Opinions recommendation of Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

D. Louis, C. Nutt, 2009 .

Supervised Bayesian latent class models for high‐dimensional data

B. Coull, C. Nutt, R. Betensky, 2012, Statistics in medicine.

Abstracts

Erwin G. Van Meir, D. Brat, K. Aldape, 1926, Lifestyle Genomics.

Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide

C. Nutt, J. Bell, D. Stojdl, 2009, Clinical Cancer Research.

Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.

J. Cairncross, C. Nutt, M. Zlatescu, 2001, Cancer research.

Inactivation of p 53 Sensitizes U 87 MG Glioma Cells to 1 , 3-bis ( 2-Chloroethyl )-1-nitrosourea 1

J. Cairncross, C. Nutt, M. Zlatescu, 2001 .

Mutations of the PIK3CA gene are rare in human glioblastoma

D. Louis, C. Nutt, M. Mizoguchi, 2005, Acta Neuropathologica.

Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.

Catherine L Nutt, John M Esposito, David N Louis, 2003, Cancer research.

YKL-40 Is a Differential Diagnostic Marker for Histologic Subtypes of High-Grade Gliomas

Rebecca A Betensky, Catherine L Nutt, Tracy T Batchelor, 2005, Clinical Cancer Research.

Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2

A. Iafrate, K. Ligon, D. Louis, 2006, Journal of neuropathology and experimental neurology.

The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas

Catherine L Nutt, Keith L Ligon, David N Louis, 2004, Journal of neuropathology and experimental neurology.

Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas: Correlation With EGFR Status, Tumor Grade, and Survival

D. Louis, T. Batchelor, C. Nutt, 2006, Journal of neuropathology and experimental neurology.

Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness

D. Louis, P. Mischel, K. Lim, 2008, The Journal of Neuroscience.

Increased expression of angiogenic genes in the brains of mouse meg3-null embryos.

C. Nutt, Yunli Zhou, Xun Zhang, 2010, Endocrinology.

Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.

D. Louis, C. Nutt, Deqin Ma, 2005, Cancer research.

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma

D. Louis, C. Nutt, A. Deimling, 2007, Oncogene.

A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma From Astrocytosis: Chromosome 7 Gain With Mutant Isocitrate Dehydrogenase 1 and p53

A. Iafrate, D. Louis, D. Dias-Santagata, 2011, Journal of neuropathology and experimental neurology.

MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

Stephen Yip, David N. Louis, A. John Iafrate, 2009, Clinical Cancer Research.

Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma

D. Louis, C. Nutt, M. Mizoguchi, 2004, Neurogenetics.

O(6)-methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes.

J. Cairncross, C. Nutt, A. Chambers, 1999, Carcinogenesis.

Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.

M Noble, M. Noble, C. Nutt, 2000, Cancer research.

Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma

K. Ligon, D. Louis, D. Rowitch, 2005, Journal of neuropathology and experimental neurology.

Molecular genetics of oligodendrogliomas: a model for improved clinical management in the field of neurooncology.

C. Nutt, 2005, Neurosurgical focus.

Glioblastomas Gene Amplification in Human Factor Receptor Epidermal Growth Microenvironmental Location Influence Mutation and TP 53 Selection Pressures of Updated

D. Louis, C. Nutt, Yoshifumi Okada, 2003 .

Computationally simple analysis of matched, outcome‐based studies of ordinal disease states

Rebecca A Betensky, Jackie Szymonifka, Eudocia Q Lee, 2015, Statistics in medicine.

Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.

D. Louis, T. Batchelor, C. Nutt, 2005, The Journal of molecular diagnostics : JMD.

Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican

S. Hockfield, C. Nutt, R. T. Matthews, 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

Advances in Brief Brain Enriched Hyaluronan Binding ( BEHAB ) / Brevican Increases Aggressiveness of CNS-1 Gliomas in Lewis Rats 1

S. Hockfield, C. Nutt, C. Zerillo, 2001 .

MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

K. Aldape, A. Iafrate, D. Louis, 2009, Clinical Cancer Research.

D. Louis, C. Nutt, Deqin Ma, 2005, Cancer research.